Sherry Dadgar

Dr. Sherry Dadgar, PhD, DABMGG, FACMG is a board certified Clinical Molecular Geneticist, healthcare entrepreneur, and precision medicine innovator committed to transforming how disease is understood and treated through integrated omics and emerging technologies. She is the Founder and CEO of Precision Medicine Care (PMC®), a precision medicine company working to bring scalable, system-driven healthcare solutions into mainstream clinical practice.

Dr. Dadgar collaborates with policymakers, academic institutions, and industry leaders to shape regulatory and economic frameworks that support innovation and patient access. PMC® was recognized by Maryland state leaders in 2025 for advancing precision medicine, and in 2026 received a Governor's Citation from the State of Maryland for outstanding service and demonstration of high integrity and ability meriting great trust and respect.

She holds leadership roles in national organizations including NILA, ACMG, and ABB, contributing to standards that influence healthcare policy and economics. Her vision is to ensure precision medicine is equitably accessible and scalable nationwide, strengthening healthcare systems and mitigating critical public health burdens.